AtaiBeckley (ATAI) Interest Coverage Ratio (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Interest Coverage Ratio came in at 0.52 in Q1 2026, up 97.69% year-on-year from 0.26 in Q1 2025, and up 97.69% quarter-over-quarter from 22.63 in Q1 2025.
AtaiBeckley (ATAI) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Interest Coverage Ratio data on file, last reported at 0.24 in Q3 2025.
- For the quarter ending Q3 2025, Interest Coverage Ratio rose 96.43% year-over-year to 0.24; the trailing twelve-month figure through Sep 2025 stood at 0.88 (up 97.21% YoY), and the FY2024 full-year result was 0.74, up 47.22% from the prior year.
- Interest Coverage Ratio rose to 0.52 in Q1 2026 per ATAI's latest filing, from 22.63 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.52 in Q1 2026 and bottomed at 22.63 in Q1 2025.
- A 5-year average of 89.66 and a median of 5.05 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio tumbled 12532.24% in 2021 and soared 11358.51% in 2024, its largest moves.
- Tracing ATAI's Interest Coverage Ratio over 5 years: stood at 0.15 in 2021, then tumbled by 47716.86% to 73.95 in 2022, then jumped by 72.04% to 20.68 in 2023, then soared by 11358.51% to 2328.08 in 2024, then plunged by 100.01% to 0.24 in 2025.
- Business Quant data shows ATAI's Interest Coverage Ratio at 0.24 in Q3 2025, 1.3 in Q2 2025, and 22.63 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.52 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -1.30 |
| Mar 31, 2025 | -22.63 |
| Mar 31, 2025 | -22.63 |
| Dec 31, 2024 | 2,328.08 |
| Sep 30, 2024 | -6.71 |
| Jun 30, 2024 | -5.05 |
| Mar 31, 2024 | -35.06 |
| Dec 31, 2023 | -20.68 |
| Sep 30, 2023 | -5.59 |
| Jun 30, 2023 | -3.12 |
| Mar 31, 2023 | -53.40 |
| Dec 31, 2022 | -73.95 |
| Sep 30, 2022 | -2.35 |
| Mar 31, 2022 | -0.96 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -613.19 |
| Mar 31, 2021 | 40.50 |
| Dec 31, 2020 | -29.08 |